Published online before print March 4, 2004, doi: 10.1161/01.ATV.0000124892.90999.cb
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper
From The Heart Research Institute, Sydney, Australia.
Correspondence to Michael J. Davies, The Heart Research Institute, 145 Missenden Road, Camperdown, Sydney, NSW 2050, Australia. E-mail m.davies{at}hri.org.au
Objective— The involvement of transition metals in atherosclerosis is controversial. Some epidemiological studies have reported a relationship between iron (Fe) and cardiovascular disease, whereas others have not. Experimental studies have reported elevated levels of iron and copper (Cu) in diseased human arteries but have often used methods that release metal ions from proteins.
Methods and Results— In this study, we have used the minimally invasive technique of electron paramagnetic resonance (EPR) spectroscopy and inductively coupled plasma mass spectroscopy (ICPMS) to quantify iron and copper in ex vivo healthy human arteries and carotid lesions. The EPR spectra detected are characteristic of nonheme Fe(III) complexes. Statistically elevated levels of iron were detected in the intima of lesions compared with healthy controls (0.370 versus 0.022 nmol/mg tissue for EPR, 0.525 versus 0.168 nmol/mg tissue by ICPMS, P<0.05 in each cases). Elevated levels of copper were also detected (7.51 versus 2.01 pmol/mg tissue, lesion versus healthy control, respectively, P<0.05). Iron levels did not correlate with the gender or age of the donor, or tissue protein or calcium levels, but cholesterol levels correlated positively with iron accumulation, as measured by EPR.
Conclusions— These data support the hypothesis that iron accumulates in human lesions and may contribute to disease progression.
Key Words: iron • copper • atherosclerosis • oxidation • free radicals • EPR
This article has been cited by other articles:
 |
|
 |
|
  W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stadler, N. Stanley, S. Heeneman, V. Vacata, M. J.A.P. Daemen, P. G. Bannon, J. Waltenberger, and M. J. Davies Accumulation of Zinc in Human Atherosclerotic Lesions Correlates With Calcium Levels But Does Not Protect Against Protein Oxidation Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 1024 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Raman, M. W. Winner III, T. Tran, M. Velayutham, O. P. Simonetti, P. B. Baker, J. Olesik, B. McCarthy, A. K. Ferketich, and J. L. Zweier In Vivo Atherosclerotic Plaque Characterization Using Magnetic Susceptibility Distinguishes Symptom-Producing Plaques J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 49 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. l. Sullivan Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability Experimental Biology and Medicine, September 1, 2007; 232(8): 1014 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Zacharski, B. K. Chow, P. S. Howes, G. Shamayeva, J. A. Baron, R. L. Dalman, D. J. Malenka, C. K. Ozaki, and P. W. Lavori Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial JAMA, February 14, 2007; 297(6): 603 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Brewer Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer's Disease Experimental Biology and Medicine, February 1, 2007; 232(2): 323 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li and B. Frei Iron Chelation Inhibits NF-{kappa}B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2638 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Carrasco-Pozo, A. Alvarez-Lueje, C. Olea-Azar, C. Lopez-Alarcon, and H. Speisky In vitro interaction between homocysteine and copper ions: potential redox implications. Experimental Biology and Medicine, October 1, 2006; 231(9): 1569 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Trivedi, C. Mallawarachi, J.-M. U-King-Im, M. J. Graves, J. Horsley, M. J. Goddard, A. Brown, L. Wang, P. J. Kirkpatrick, J. Brown, et al. Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1601 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. van der A, J. J.M. Marx, D. E. Grobbee, M. H. Kamphuis, N. A. Georgiou, J. H. van Kats-Renaud, W. Breuer, Z. I. Cabantchik, M. Roest, H. A.M. Voorbij, et al. Non-Transferrin-Bound Iron and Risk of Coronary Heart Disease in Postmenopausal Women Circulation, April 25, 2006; 113(16): 1942 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rosenblat, L. Gaidukov, O. Khersonsky, J. Vaya, R. Oren, D. S. Tawfik, and M. Aviram The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux J. Biol. Chem., March 17, 2006; 281(11): 7657 - 7665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|